Barbara N Lubash's Net Worth

$709 Million

Who is Barbara N Lubash?

Barbara N Lubash has an estimated net worth of $709 Million. This is based on reported shares across multiple companies, which include INSULET CORP, PHASERX, INC., Flexion Therapeutics Inc, GLAUKOS Corp, Inogen Inc, SECOND SIGHT MEDICAL PRODUCTS INC, NOVACEA INC, GENOMIC HEALTH INC, INTRALASE CORP, Alexza Pharmaceuticals Inc., and HELICOS BIOSCIENCES CORP.

SEC CIK

Barbara N Lubash's CIK is 0001279592

Past Insider Trading and Trends

2014 was Barbara N Lubash's most active year for acquiring shares with 45 total transactions. Barbara N Lubash's most active month to acquire stocks was the month of April. 2014 was Barbara N Lubash's most active year for disposing of shares, totalling 38 transactions. Barbara N Lubash's most active month to dispose stocks was the month of April. 2016 saw Barbara N Lubash paying a total of $12,999,990.00 for 1,449,369 shares, this is the most they've acquired in one year. In 2016 Barbara N Lubash cashed out on 807,291 shares for a total of $819,291.28, their largest year based on trade value.